DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

67.26 0.24 (0.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $67.26 0.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $65.43
Previous Close $67.02
Daily Range $65.03 - $68.89
52-Week Range $62.12 - $151.75
Market Cap $10.8B
P/E Ratio -33.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,641,820
Average Daily Volume 1,965,725
Current FY EPS -$0.49

Sector

Healthcare

Industry

Drug Makers

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

Why Sarepta Therapeutics Inc. Is Down Today

News of a pushback in its PDUFA date sends shares lower.

The Touchstone Sands Capital Institutional Growth Fund Is Feeling The Pain

Will Teva (TEVA) Continue with its Earnings Streak in Q4?

Nasdaq 100 Movers: VIAB, AKAM

Sarepta Hits 52-Week Low; Eteplirsen Review Period Extended

Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Cat

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

VXF, LNKD, INCY, BMRN: ETF Outflow Alert

Why Shares of Sarepta Therapeutics Inc. Collapsed in January

Harsh words from a FDA advisory committee report have investors fearing the worst.

Recent Setbacks Have Duchenne Investors On Edge

See More BMRN News...

BMRN's Top Competitors

BMRN $67.26 (0.36%)
Current stock: BMRN
AMGN $141.46 (-1.63%)
Current stock: AMGN
GILD $87.36 (-0.50%)
Current stock: GILD
BIIB $245.11 (-2.81%)
Current stock: BIIB